position: EnglishChannel  > Insight> U.S. Limitations on Chinese Influence in Academia Risk Backfiring

U.S. Limitations on Chinese Influence in Academia Risk Backfiring

Source: Science and Technology Daily | 2024-01-10 11:32:20 | Author: Staff?Reporters


A sign is displayed at the University at Buffalo in Amherst, New York. (PHOTO: VCG)

The academic decoupling of the United States and China began a little more than five years ago after U.S. government agencies began to crackdown on academic collaborations, fearing that close ties between American and Chinese universities, scholars, and scientists were threatening the national security of the United States.

Recent research has demonstrated that the Department of Justice’s China Initiative curtailed U.S.-China academic collaboration, resulting in fewer publications and patents for U.S.-based scientists, and increased the number of Chinese-born scientists seeking to leave the United States.

Restrictions and guardrails to protect scientific integrity and national security should be applicable to all, not based on ethnicity or national origin. Universities should work in tandem with government agencies to implement rules that are transparent and narrowly tailored to restrict certain types of research.

Mary Gallagher, US Efforts to Limit Chinese Influence in Academia Risk Backfiring, World Politics Review, 26-12-2023



Editor:汤哲枭

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的浏览器版本过低或开启了浏览器兼容模式,这会影响您正常浏览本网页

您可以进行以下操作:

1.将浏览器切换回极速模式

2.点击下面图标升级或更换您的浏览器

3.暂不升级,继续浏览

继续浏览